New Drug Shows Promise for Kidney Cancer

A City of Hope-led study has found that a new experimental targeted therapy called tivozanib may be better for repeat kidney cancer patients than its FDA-approved counterpart.

New Drug Shows Promise for Kidney Cancer
QR Code
Embed the QR code on your website:
Download
Copy